We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1626
DELISTED
Immunomedics Inc
IMMU
| $367K | ﹤0.01% |
+100,000
| New | +$296K |
|
1627
Omega Healthcare
OHI
$15.3B
| $366K | ﹤0.01% |
11,723
-15,988
| -58% | -$493K |
|
1628
UDR
UDR
$12.8B
| $366K | ﹤0.01% |
10,021
-9,700
| -49% | -$332K |
|
|
FIT
1629
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $366K | ﹤0.01% |
+50,012
| New | +$512K |
|
1630
CALL
Bausch Health
BHC
$1.67B
| $363K | ﹤0.01% |
25,000
-61,400
| -71% | -$1.13M |
|
|
FCB
1631
DELISTED
FCB Financial Holdings, Inc.
FCB
| $363K | ﹤0.01% |
+7,600
| New | +$315K |
|
|
MBFI
1632
DELISTED
MB Financial Corp
MBFI
| $362K | ﹤0.01% |
7,668
-6,696
| -47% | -$277K |
|
1633
Radian Group
RDN
$5.18B
| $361K | ﹤0.01% |
+20,096
| New | +$302K |
|
|
ASRT
1634
PUT
DELISTED
Assertio
ASRT
| $360K | ﹤0.01% |
+333
| New | +$424K |
|
1635
Saia
SAIA
$11.2B
| $360K | ﹤0.01% |
+8,151
| New | +$315K |
|
1636
Chord Energy
CHRD
$7.42B
| $358K | ﹤0.01% |
23,601
-7
| -0% | -$91 |
|
|
PEGI
1637
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $358K | ﹤0.01% |
+18,867
| New | +$388K |
|
1638
Avista
AVA
$3.43B
| $357K | ﹤0.01% |
+8,922
| New | +$361K |
|
1639
Huron Consulting
HURN
$1.89B
| $357K | ﹤0.01% |
+7,046
| New | +$376K |
|
1640
CAE Inc. Common Shares
CAE
$8.3B
| $356K | ﹤0.01% |
+25,500
| New | +$364K |
|
|
ACTA
1641
DELISTED
Actua Corp
ACTA
| $354K | ﹤0.01% |
+25,300
| New | +$333K |
|
|
ALEX
1642
DELISTED
Alexander & Baldwin
ALEX
| $352K | ﹤0.01% |
+7,859
| New | +$328K |
|
1643
Larimar Therapeutics
LRMR
$398M
| $352K | ﹤0.01% |
+9,227
| New | +$374K |
|
1644
Alamos Gold
AGI
$12.5B
| $351K | ﹤0.01% |
+51,000
| New | +$358K |
|
|
EVER
1645
DELISTED
Everbank Financial Corp
EVER
| $350K | ﹤0.01% |
+18,017
| New | +$349K |
|
1646
BlackBerry
BB
$4.93B
| $349K | ﹤0.01% |
50,700
+5,100
| +11% | +$37.9K |
|
|
CADE
1647
DELISTED
Cadence Bank
CADE
| $348K | ﹤0.01% |
11,212
-21,449
| -66% | -$575K |
|
|
CBL
1648
DELISTED
CBL& Associates Properties, Inc.
CBL
| $347K | ﹤0.01% |
30,149
-77,995
| -72% | -$904K |
|
|
PPLT
1649
abrdn Physical Platinum Shares ETF
PPLT
$1.85B
| $346K | ﹤0.01% |
40,000
-35,000
| -47% | -$317K |
|
1650
Pan American Silver
PAAS
$18.6B
| $345K | ﹤0.01% |
22,900
-16,277
| -42% | -$262K |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.